The Indianapolis drugmaker quietly terminated a collaboration with NextCure Inc. after spending $40 million on an up-front fee and equity investment, and with little to show from the partnership.
After raking in record amounts of venture capital funding in 2017 and 2018, Indiana life science companies saw funding drop last year by double-digits, while the average deal amount dipped sharply as well.
Dr. Anantha Shekhar, a nationally recognized health sciences researcher and entrepreneur, has played a major role in boosting research funding at IU, where he has worked since 1989 in numerous leadership roles.
The year didn’t feature any hostile takeovers or huge disasters. But a lot of companies made big strides in 2019, including Eli Lilly and Co., Corteva and Elanco. And many rejoiced when Washington ended a 2.3% tax on thousands of medical devices.
The repeal ends a 2.3% tax on thousands of medical devices, from stents and catheters to pacemakers and MRI machines. Indiana is home to 155 device-makers, ranging from small metal shops to multibillion-dollar manufacturers.
To satisfy House Democrats, the Trump administration removed a provision that would have given the makers of ultra-expensive biologic drugs 10 years of protection from less expensive knockoffs.
CEO Gail Boudreaux’s recent comments at a health care summit dampened speculation that Anthem might create its own physician group, something the insurer tried unsuccessfully two decades ago.
Neuropsychiatric Hospitals LLC said it is developing a 64-bed hospital in Greenwood that will serve patients with complex medical and psychiatric condition.
Fishers-based Aggressively Organic Inc., an agricultural technology company that focuses on alleviating food insecurity, announced plans in 2017 to hire 200 people by the end of 2021.
Medistar Corp. of Texas has filed an application to build a 42,610-square-foot building at 795 North Emerson Avenue, a vacant and undeveloped site about a mile south of Franciscan Health Indianapolis.
The expansion is the latest move by a large Indianapolis health system to expand cancer care, a fast-growing and competitive medical field.
Indianapolis-based Cornerstone Cos. has invested more than $84 million in recent years to buy medical office buildings, clinics and surgery centers. Now it is about to start its fifth investment fund.
The company said it needs more space after acquiring six laser beam printers. In the past decade, more than 600 spine surgeons have performed procedures using Nexxt Spine products.
The exhibit, which opens Feb. 1, covers 7,000 square feet and invites visitors to “unravel the crisis one step at a time,” with displays on the biology behind addictions, American history with other health crises, and personal stories from addicts and families.
The latest lawsuit says the company targeted young people for its flavored e-cigarettes without warning that the products were highly addictive and dangerous.
One in six Hoosier children aged 10 to 17 is obese, making Indiana among the worst states in the nation for childhood obesity, according to a new study from the Robert Wood Johnson Foundation.
The Indianapolis-based company’s software employs machine learning to prevent health systems from ordering too many or too few tests, a mistake that can lead to missed diagnoses and costly procedures.
One of Indiana’s oldest and largest senior communities has broken ground on its fifth addition in seven years. Owner BHI Senior Living says it has a “robust waiting list” at Hoosier Village.
The new venture, called MBX Biosciences Inc., aims to develop therapeutics to treat rare endocrine disorders. The company has already raised $2.5 million in funding.
Capitol Village Healthcare, a 52-bed nursing home at 2926 N. Capitol Ave., closed earlier this year, and had received low ratings from U.S. News and the Centers for Medicare & Medicaid Services.